Loading...
COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”
The novel coronavirus which emerged in Wuhan province of China has taken world by surprise. Since been diagnosed in December 2019, it has been termed a “Pandemic” and there is a growing concern in physicians across the globe. As new evidence is emerging, there are various preventative strategies whi...
Saved in:
| Published in: | Egypt J Neurol Psychiatr Neurosurg |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Berlin Heidelberg
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194245/ https://ncbi.nlm.nih.gov/pubmed/32372857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41983-020-00177-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|